(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

V-PUPSIT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

V-PUPSIT

ST13

US500000079356168

Class

5, 39, 42

Filing

79356168

Registration

7362174

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

11/09/2024

Trademark type

Word

Nice classes

5, 39, 42

Filing date

06/15/2022

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

04/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

STEINPFAD, SARAH E

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vetter Pharma-Fertigung GmbH & Co. KG

Representatives

M. Scott Alprin Alprin Law Offices, P.C.

Technical classification

Nice Classes

Class 5Class 39Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Aseptically manufactured pharmaceutical preparations and drugs for the prevention of infectionscancerdepressionheart diseasesvascular diseasesintestinal disorderlung and bronchial disfunctionliver disfunctioninflammation and inflammatory diseasesoral and laryngeal diseaseoptical and cranial disordersarthritismigrainemucopolysaccharidosishaemophiliamultiple sclerosisosteoporosisneuronal disordersdiabeteserectile disfunctioninfertilitycrohn's diseasehereditary angioedemathrombosisencephalitisdiseases of the thyroid or parathyroid glandsmetabolic diseasesmuscular atrophydisturbance of growth and anemia; pharmaceutical preparations to be taken orally and sterileaseptic solutions and injection solutions for the prevention of infectionscancerdepressionheart diseasesvascular diseasesintestinal disorderlung and bronchial disfunctionliver disfunctioninflammation and inflammatory diseasesoral and laryngeal diseaseoptical and cranial disordersarthritismigrainemucopolysaccharidosishaemophiliamultiple sclerosisosteoporosisneuronal disordersdiabeteserectile disfunctioninfertilitycrohn's diseasehereditary angioedemathrombosisencephalitisdiseases of the thyroid or parathyroid glandsmetabolic diseasesmuscular atrophydisturbance of growth and anemia; eye dropscontact lens solutions; swabs for medical purposes; medical plasters; materials for medical dressingscompressessterile padsgauzeplastic filmsgelsfoamshydrocolloidsalginatespastesgranules and beads

Class 39

Bottling servicesasepticsterile bottling of substances

Class 42

Scientific research and development in the field of aseptic and sterile bottling services of substances and syringes for injections and instrumentsinjectors and associated packaging; engineering serviceschemicalphysical and process engineering laboratory testing; testing of pharmaceuticalsconducting of microbiological tests and procedures for others

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/09/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/23/2024

FIMP

FINAL DISPOSITION PROCESSED

10/23/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/24/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2024

PUBO

PUBLISHED FOR OPPOSITION

02/06/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/17/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2024

DOCK

ASSIGNED TO EXAMINER

11/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/14/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/14/2023

RFNT

REFUSAL PROCESSED BY IB

06/12/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/17/2023

RFRR

REFUSAL PROCESSED BY MPU

05/17/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/29/2023

CNRT

NON-FINAL ACTION WRITTEN

03/28/2023

DOCK

ASSIGNED TO EXAMINER

03/28/2023

MAFR

APPLICATION FILING RECEIPT MAILED

12/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/02/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/01/2022

Continuous trademark protection

Get notified about every new filing that threatens V-PUPSIT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.